P

Inventor

HUNG MIEN-CHIE

US36 patents
⚠️ This page may combine multiple inventors who share the name “HUNG MIEN-CHIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV TEXAS

24 patents
US5641484AJun 24, 1997

Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen

UNIV TEXAS59 citations93
US6683059B1Jan 27, 2004

Mini-E1A gene and gene products

UNIV TEXAS14 citations92
US6197754B1Mar 6, 2001

Suppression of tumor growth by a mini-E1A gene

UNIV TEXAS20 citations92
US5653974AAug 5, 1997

Preparation and characterization of liposomal formulations of tumor necrosis factor

UNIV TEXAS63 citations91
US5651964AJul 29, 1997

Methods for the suppression of neu mediated tumors by the adenoviral EIA gene

UNIV TEXAS46 citations91
US5643567AJul 1, 1997

Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen

UNIV TEXAS41 citations91
US5922688AJul 13, 1999

PEA3 is a tumor suppressor

UNIV TEXAS30 citations90
US7316907B2Jan 8, 2008

14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types

UNIV TEXAS17 citations89
US6395712B1May 28, 2002

Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy

UNIV TEXAS22 citations89
US7816131B2Oct 19, 2010

Cancer specific promoters

UNIV TEXAS10 citations80
US6248351B1Jun 19, 2001

Human PEA3 is a tumor suppressor for cancer cells

UNIV TEXAS8 citations71
US5814315ASep 29, 1998

Methods for the suppression of neu mediated phenotype in tumors

UNIV TEXAS13 citations69
US6172212B1Jan 9, 2001

Pea3 is a tumor suppressor

UNIV TEXAS2 citations60
US7005424B2Feb 28, 2006

Nucleic acid encoding an E1A gene product sensitizes HER-2/neu overexpressing cancer cells to chemotherapy

UNIV TEXAS2 citations59
US7906628B2Mar 15, 2011

Targeting proteins to deliver therapeutic or diagnostic reagents

UNIV TEXAS3 citations56
US7893033B2Feb 22, 2011

Targeting proteins to deliver therapeutic or diagnostic reagents

UNIV TEXAS3 citations56
US11452775B2Sep 27, 2022

Detection of arginine methylation of EGFR for prediction of resistance to therapy

UNIV TEXAS0 citations53
US6331284B1Dec 18, 2001

P202 is a tumor suppressor

UNIV TEXAS5 citations53
US10451610B2Oct 22, 2019

Prediction of response to PARP inhibitors and combinational therapy targeting C-MET and PARP1

UNIV TEXAS0 citations51
US7709205B2May 4, 2010

14-3-3 Zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type

UNIV TEXAS0 citations49
US6582725B2Jun 24, 2003

Human PEA3 is a tumor suppressor for cancer cells

UNIV TEXAS0 citations49
US7723104B2May 25, 2010

Cancer specific promoters

UNIV TEXAS0 citations48
US10537635B2Jan 21, 2020

Detection of arginine methylation of EGFR for prediction of resistance to therapy

UNIV TEXAS0 citations43
US9655909B2May 23, 2017

Personalized medicine for the prediction of therapy targeting the hedgehog pathway

UNIV TEXAS0 citations40

STCUBE INC

6 patents

UNIV CHINA MEDICAL

2 patents

STCUBE & CO INC

1 patent

HUNG MIEN-CHIE

1 patent

KAMEOKA JUN

1 patent

KUO KWANG BIOTECH CORP

1 patent